Chan J C, East J L, Dmochowski L
Cancer Res. 1975 Sep;35(9):2475-81.
Inoculation of the Soehner-Dmochowski isolate of the Moloney strain of murine sarcoma virus (MSV), designated MSV-SD, consistently leads to the development of bone tumors in the susceptible New Zealand black (NB) rats. Two separate cell cultures have been established from 2 individual MSV-SD-induced NB rat bone tumors. Cells of 1 bone tumor culture, designated RBT-E, are in early in vitro passages. These cells form colonies in agar medium and take up 2-deoxy-D-[3H]glucose at a greatly enhanced rate, 5 times that of normal nontransformed rat embryo cells. Cells of the RBT-E culture release both MSV and murine leukemia virus (MuLV) and therefore contain sarcoma-positive leukemia-positive transformed cells. The other rat bone tumor culture, designated RBT-L, produced MSV at early passages. RBT-L culture has been passaged over 130 times in vitro. Cells of the RBT-L culture form colonies in agar medium and take up 2-deoxy-D-[3H]glucose at an enhanced rate (3 times that of rat embryo cells), indicating the presence of transformed cells within the RBT-L culture. However, cells of the RBT-L culture at late passages (Passage 130 or more) produce only MuLV and no detectable MSV activity (as shown by the lack of tumor-inducing activity and the lack of focus-forming activities by direct assay or by infectious center assay). Attempts to rescue MSV activity from RBT-L cells by cocultivation with MuLV-producing mouse cells were not successful. The MuLV found in the RBT-L cells, however, is a competent helper virus capable of rescuing the MSV genome from MSV-SD-induced hamster bone tumor cells. All the available evidence supports the notion that late passages of the RBT-L culture contain transformed cells that do not produce conventionally detectable MSV. These cells are referred to as sarcoma-negative leukemia-positive cells. The sarcoma-negative leukemia-positive cells represent a different kind of MSV-induced transformed cells and provide a unique system for studies in search of MSV markers such as MSV-specific antigens and MSV-specific nucleotide sequences.
接种莫洛尼鼠肉瘤病毒(MSV)的索纳-德莫霍夫斯基分离株,即MSV-SD,在易感的新西兰黑(NB)大鼠中始终会引发骨肿瘤。从2个单独的MSV-SD诱导的NB大鼠骨肿瘤中建立了两种不同的细胞培养物。一种骨肿瘤培养物的细胞,命名为RBT-E,处于体外早期传代阶段。这些细胞在琼脂培养基中形成集落,并以显著提高的速率摄取2-脱氧-D-[3H]葡萄糖,是正常未转化大鼠胚胎细胞摄取速率的5倍。RBT-E培养物的细胞释放MSV和鼠白血病病毒(MuLV),因此含有肉瘤阳性白血病阳性的转化细胞。另一种大鼠骨肿瘤培养物,命名为RBT-L,在早期传代时产生MSV。RBT-L培养物已在体外传代超过130次。RBT-L培养物的细胞在琼脂培养基中形成集落,并以提高的速率摄取2-脱氧-D-[3H]葡萄糖(是大鼠胚胎细胞摄取速率的3倍),表明RBT-L培养物中存在转化细胞。然而,RBT-L培养物后期传代(第130代或更高)的细胞仅产生MuLV,未检测到MSV活性(通过直接检测或感染中心检测缺乏肿瘤诱导活性和集落形成活性可证明)。通过与产生MuLV的小鼠细胞共培养从RBT-L细胞中拯救MSV活性的尝试未成功。然而,在RBT-L细胞中发现的MuLV是一种有能力的辅助病毒,能够从MSV-SD诱导的仓鼠骨肿瘤细胞中拯救MSV基因组。所有现有证据支持这样的观点,即RBT-L培养物的后期传代含有不产生传统可检测MSV的转化细胞。这些细胞被称为肉瘤阴性白血病阳性细胞。肉瘤阴性白血病阳性细胞代表了一种不同类型的MSV诱导的转化细胞,并为寻找MSV标志物(如MSV特异性抗原和MSV特异性核苷酸序列)的研究提供了一个独特的系统。